Suppressive activity of epinastine hydrochloride on eosinophil activation in vitro

In Vivo

Volumn 22, Issue 1, 2008, Pages 13-20

  Mochizuki, Yu Ichiro ^a   Furuta, Atsuko ^a   Furuya, Ayako ^a   Kanai, Ken Ichi ^a   Asano, Kazuhito ^a   Suzaki, Harumi ^a  

^a SHOWA UNIVERSITY   (Japan)

Author keywords

Activation; Eosinophil; Epinastine; Suppression

Indexed keywords

EPINASTINE; IMMUNOGLOBULIN E; LEUKOTRIENE C4; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; RANTES; STEM CELL FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CULTURE; CELL STIMULATION; CESTODIASIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG MECHANISM; EOSINOPHIL; EOSINOPHIL COUNT; EOSINOPHILIA; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN PRODUCTION; IN VITRO STUDY; IN VIVO STUDY; LEUKOCYTE ACTIVATION; LEUKOCYTE FUNCTION; MALE; MESOCESTOIDEA; MOUSE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN CONTENT; PROTEIN SYNTHESIS INHIBITION; RECOMMENDED DRUG DOSE; SUPERNATANT; TREATMENT DURATION;

EID: 40749115176     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Hogan SP: Recent advances in eosinophil biology. Int Arch Allergy Immunol 143(Suppl 1): 3-14, 2007.
2. Gleich GJ: Mechanisms of eosinophil-associated inflammation. J Allergy Clin Immunol 105: 651-663, 2000
3. Widegren H, Korsgren M, Andersson M and Greiff L: Effects of TNFalpha on the human nasal mucosa in vivo. Respir Med 101: 1982-1087, 2007.
4. Erjefalt JS, Greiff L, Andersson M, Matsson E, Petersen H, Linden M, Ansari T, Jeffery PK and Persson CGA: Allergen-induced eosinophil cytolysis is a primary mechanism for granule protein release in human upper airways. Am J Respir Crit Care Med 160: 304-312, 1999.
5. Davoine F, Ferland C, Chakir J, Lee JE, Adamko DJ, Moqbel R and Laviolette M: Interleukin-12 inhibits eosinophil degranulation and migration but does not promote eosinophil apoptosis. Int Arch Allergy Immunol 140: 277-284, 2006.
6. Hur GY, Lee SY, Lee SH, Kim SJ, Lee KJ, Jung JY, Lee EJ, Kang EH, Jung KH, Lee SY, Kim JH, Shin C, Shim JJ, In KH, Kang KH and Yoo SH: Potential use of an anticancer drug gefinitib, an EGFR inhibitor, on allergic inflammation. Exp Mol Med 39: 367-375, 2007.
7. Asano K, Sugimoto K, Watanabe T, Hisano M and Hisamitsu T: Suppressive effects of the Chinese herbal remedy Tripterygium wilfordii Hook f on eosinophilia and IgE hyperproduction in mice. Allergol Int 49: 37-45, 2000.
8. Dold S, Heinrich J, Wichmann EH and Wist M: Ascaris-specific IgE and allergic sensitization in a cohort of school children in the former East Germany. J Allergy Clin Immunol 102: 414-420, 1998.
9. The Physiological Society of Japan: Guidline Principles for the Care and Use of Animals in the Field of Physiological Science. J Physiol Society Japan 51: 289-290, 1990.
10. Korenaga M, Hitoyoshi Y, Takatsu K and Tada I: Cross-resistance between Strongyloides benezuelensis and S. ratti in mice. J Helminthol 69: 119-123, 1995.
11. Tasaka K: Epinastine: an update of its pharmacology, metabolism, clinical efficacy and tolerability in the treatment of allergic diseases. Drug Today 36: 735-757, 2000.
12. Tamachi T, Watanabe N, Oya Y, Kagami S, Hirose K, Saito Y, Iwamoto I and Nakajima H: B and T lymphocyte attenuator inhibits antigen-induced eosinophil recruitment into the airways. Int Arch Allergy Immunol 143(Suppl 1): 50-55, 2007.
13. Schleimer RP and Bochner BS: The effects of glucocorticoids on human eosinophils. J Allergy Clin Immunol 94: 1202-1203, 1994.
14. Conroy DM and Williams TJ: Eotaxin and the attraction of eosinophils to the asthmatic lung. Respir Res 2: 150-156, 2001.
15. Oliveira SHP, Taub DD, Nagel J, Smith R, Hogaboam CM, Berlin A and Lukacs NW: Stem cell factor induces eosinophil activation and degranulation: mediator release and gene array analysis. Blood 100: 4291-4297, 2002.
16. 1 receptor antagonist, in adults and children. Br J Clin Pharmacol 59: 43-53, 2005.
17. Ogawa Y and Calhoun WJ: The role of leukotrienes in airway inflammation. J allergy Clin Immunol 118: 789-798, 2006.
18. Salvi SS, Krishna MT, Sampson AP and Holgate ST: The anti-inflammatory effects of leukotrienes-modifying drugs and their use in asthma. Chest 119: 1533-1546, 2001.
19. Dranz JM, Israel E and O'Byrne PM: Treatment of asthma with drugs modifying the leukotriene pathway. N Engl J Med 340: 197-206, 1999.
20. Calderon MA, Lozewicz S, Prior A, Jordan S, Trigg CJ and Davies RJ: Lymphocyte infiltration and thickness of the nasal mucus membrane in perennial and seasonal allergic rhinitis. J Allergy Clin Immunol 93: 635-643, 1994.
21. Oyamada H, Kamada Y, Saito N, Tsuda A, Urayama O, Yamada H, Hirasawa H, Yamaguchi K, Ueki S and Chihara J: RANTES production from mononuclear cells in response to the specific allergen in asthma patients. Allergol Int 55: 253-259, 2006.
22. Niimi K, Asano K, Shiraishi Y, Nakajima T, Wakaki M, Kagyo J, Takihara T, Suzuki Y, Fukunaga K, Shiomi T, Oguma T, Sayama K, Yamaguchi K, Natori Y, Matsumoto M, Seya T, Yamaya M and Ishizaka A: TLR-3 mediated synthesisi and release of eotaxin-1/CCL11 from human bronchial smooth muscle cells stimulated with double-strand RNA. J Immunol 178: 489-495, 2007.
23. Tahan F, Karaaslan C, Aslan A, Kiper N and Kalayci O: The role of chemokines in exercised-induced bronchoconstriction in asthma. Ann Allergy Asthma Immunol 96: 819-825, 2006.
24. Haelens A, Wuyts A, Proost P, Struyf S, Opedenaller G and van Damme J: Leukocyte migration and activation by murine chemokines. Immunobiol 195: 499-521, 1996.
25. Aliberti JC, Machado FS, Souto JT, Campanelli AP, Teixeira MM, Gazzinelli RT and Silva JS: Beta-chemokines enhance parasite uptake and promote nitric oxide-dependent microbiostatic activity in murine inflammatory macrophages infected with Trypanosoma cruzi. Infect Immun 67: 4819-4826, 1999.
26. Berridge MJ and Irvine RF: Inositol phosphate and cell signaling. Nature 341: 197-205, 1989.
27. Gupta S, Banfield C, Kanteesaria B, Marino M, Clement R, Affrime M and Batra V: Pharmacokinetics and safety profile of desloratadine and fexofenadine when coadministered with azithromycine: A randomized, placebo-controlled, parallel-group study. Clin Ther 23: 451-466, 2001.
28. Gelfand EW, Cui ZH, Takeda K, Kanehiro A and Joetham A: Fexofenadine modulates T-cell function, preventing allergen-induced airway inflammation and hyperresponssiveness. J Allergy Clin Immunol 110(Suppl 4): S85-95, 2002.
29. Masuo M, Shimada T and Kitazawa T: Mechanism of inhibitory effect of azelastine on muscle contraction. J Pharmacol Exp Ther 26: 1300-1308, 1992.